Medical Regulation

The Fatal Flaws in the “Abortion Pill” Decision

The Fatal Flaws in the “Abortion Pill” Decision

By second-guessing FDA safety determinations, the Fifth Circuit challenges the Supreme Court to restore agency deference.

Medical Debt Collection

Medical Debt Collection

Experts discuss how regulators can protect consumers from aggressive collection practices.

FDA, Not a Federal Judge, Should Decide on Abortion Drugs

FDA, Not a Federal Judge, Should Decide on Abortion Drugs

Anti-abortion advocates take aim at FDA approval and regulation of the abortion drug mifepristone, threatening access nationwide.

FDA Advances Program for Real-World Evidence

FDA Advances Program for Real-World Evidence

FDA’s approach to evidence-based decision-making may not be addressed to the right people.

Underrepresented, Overmedicated, and Misdiagnosed

Underrepresented, Overmedicated, and Misdiagnosed

Experts contend that FDA clinical trials fail to ensure adequate consideration of women’s health needs.

Expanding FDA Incentives to Boost Diversity in Clinical Trials

Expanding FDA Incentives to Boost Diversity in Clinical Trials

Exploring FDA’s toolkit for encouraging study sponsors to meet diversity goals.

Reforming Health Care for Patients in Prison

Reforming Health Care for Patients in Prison

Scholars discuss the lack of uniform standards for health care provided behind bars.

My Body, Whose Choice?

My Body, Whose Choice?

States should require doctors to seek informed consent before performing pelvic exams on anesthetized women.

Proposed Rule Seeks to Promote Value-Based Health Care

Proposed Rule Seeks to Promote Value-Based Health Care

Federal regulators seek to expand safe harbors for provider care coordination arrangements.

How FDA Drug Review Contributed to the Opioid Epidemic

How FDA Drug Review Contributed to the Opioid Epidemic

Scholars argue that FDA should use larger health data sets in its approval process for high-risk drugs.

Proposed Rule Aims to Make Drug Pricing More Transparent

Proposed Rule Aims to Make Drug Pricing More Transparent

A proposed requirement to display drug list prices in advertisements draws controversy.

Regulatory Collaboration Is Key to Public Health Success

Regulatory Collaboration Is Key to Public Health Success

Federal health agencies should work together to address public health problems.